SCHEMBL613453

SCHEMBL613453

CCCC#CCc1[c]cccc1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.31
TLR8 Q9NR97 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8127639 0.88 KCNH2 (0.41) PTGS2
SCHEMBL8114611 0.86 KCNH2 (0.44) PTGS2
SCHEMBL8113700 0.86 KCNH2 (0.44) PTGS2
SCHEMBL614942 0.85
SCHEMBL8112510 0.82 KCNH2 (0.33) PTGS2
SCHEMBL483302 0.79
SCHEMBL8122307 0.75 KCNH2 (0.36) PTGS2
SCHEMBL6452089 0.75
SCHEMBL614588 0.74
SCHEMBL8114659 0.73 KCNH2 (0.44) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160367639-A1 MODIFICATION OF FEEDING BEHAVIOR IMPERIAL INNOVATIONS LIMITED (GB) 2016-12-22 US disclosed
EP-2329839-B1 Modification of feeding behavior by GLP-1 and PYY IMP INNOVATIONS LTD (GB) 2015-09-16 EP disclosed
US-20150051140-A1 MODIFICATION OF FEEDING BEHAVIOR IMPERIAL INNOVATIONS (GB) 2015-02-19 US disclosed
US-8217001-B2 Modification of feeding behavior IMPERIAL INNOVATIONS LIMITED 2012-07-10 US disclosed
US-20120040893-A1 MODIFICATION OF FEEDING BEHAVIOUR COWLEY MICHAEL (AU) 2012-02-16 US disclosed
US-8058233-B2 adminsteration of Peptide YY and glucagons-like peptide-1( GLP-1) or agonists to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism OREGON HEALTH AND SCIENCE UNIVERSITY (US) 2011-11-15 US disclosed
EP-2329839-A1 Modification of feeding behavior by GLP-1 and PYY Imperial Innovations Limited (GB) 2011-06-08 EP disclosed
US-7919329-B2 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia OREGON HEALTH & SCIENCE UNIVERSITY (US) 2011-04-05 US disclosed
US-20090209461-A1 MODIFICATION OF FEEDING BEHAVIOR IMPERIAL COLLEGE INNOVATIONS LTD. (GB) 2009-08-20 US disclosed
EP-2050460-A1 PYY and agonists thereof for modification of feeding behaviour Imperial Innovations Limited (GB) 2009-04-22 EP disclosed
US-20050015820-A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-01-20 US disclosed
EP-1474163-A2 MODIFICATION OF FEEDING BEHAVIOR Imperial College Innovations Limited (GB) 2004-11-10 EP disclosed
WO-2003026591-A9 MODIFICATION OF FEEDING BEHAVIOR IMP COLLEGE INNOVATIONS LTD (GB) 2004-07-08 WO disclosed
EP-1137631-B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE UNIV SOUTHERN CALIFORNIA (US) 2004-04-28 EP disclosed
WO-2003057235-A2 MODIFICATION OF FEEDING BEHAVIOR IMPERIAL COLLEGE INNOVATIONS LTD (GB) 2003-07-17 WO disclosed
US-6590071-B1 Increasing the delivery of hydrophilic amine containing compounds to the cell having a mucosal barrier, in which a compound of given formula penetrates the mucosal barrier of the cell; free amine is liberated by hydrolysis UNIVERSITY OF SOUTHERN CALIFORNIA 2003-07-08 US disclosed
WO-2003027637-A2 ASSESSMENT OF NEURONS IN THE ARCUATE NUCLEUS TO SCREEN FOR AGENTS THAT MODIFY FEEDING BEHAVIOR OREGON HEALTH AND SCIENCE UNIVERSITY (US) 2003-04-03 WO disclosed
WO-2003026591-A2 MODIFICATION OF FEEDING BEHAVIOR IMPERIAL COLLEGE INNOVATIONS LTD. (GB) 2003-04-03 WO disclosed
EP-1137631-A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2001-10-04 EP disclosed
WO-2000034236-A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2000-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209461-A1 MODIFICATION OF FEEDING BEHAVIOR NPY4R, NPY5R, NPY2R PTGS2 2963/4885TLR8 2310/4885
US-20150051140-A1 MODIFICATION OF FEEDING BEHAVIOR GLP1R, NPY4R, NPY1R PTGS2 3765/4885TLR8 2046/4885
US-20120040893-A1 MODIFICATION OF FEEDING BEHAVIOUR GLP1R, NPY4R, NPY1R PTGS2 3648/4885TLR8 2049/4885
US-20160367639-A1 MODIFICATION OF FEEDING BEHAVIOR GLP1R, NPY4R, NPY1R PTGS2 3765/4885TLR8 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.